The Institute for Clinical and Economic Review
April 9, 2019
Patients, in consultation with their doctors, should make their own medical decisions. But with increasing frequency, an outside organization known as the Institute for Clinical and Economic Review is influencing what treatment options are available for consideration. Today, patients’ access to innovative drugs, life-saving devices and diagnostic testing often rides on this third-party’s value assessment.
Tags: InnovationCategorized in: Fast Facts, Policy Papers